Cell-free supernatants of probiotic consortia impede hyphal formation and disperse biofilms of vulvovaginal candidiasis causing Candida in an ex-vivo model
Vulvovaginal candidiasis is the second most common vaginal infection caused by drug-resistant Candida species that affects about 70–75% of reproductive age group women across the globe. As current-day antifungal drugs are ineffective against the biofilms formed by the drug-resistant Candida strains,...
Saved in:
Published in | Antonie van Leeuwenhoek Vol. 117; no. 1; p. 37 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.12.2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0003-6072 1572-9699 1572-9699 |
DOI | 10.1007/s10482-024-01929-1 |
Cover
Summary: | Vulvovaginal candidiasis is the second most common vaginal infection caused by drug-resistant
Candida
species that affects about 70–75% of reproductive age group women across the globe. As current-day antifungal drugs are ineffective against the biofilms formed by the drug-resistant
Candida
strains, several natural compounds and antagonistic microbes are being explored as alternative antifungal agents. In the present study, we investigated the anti-biofilm activity of Cell-Free Supernatant (CFS) extracted from the commercially available probiotics VSL-3 against the biofilms of
Candida
species and also evaluated their efficacy in curbing the yeast-to-hyphal transition. Various methodologies like crystal violet staining and scanning electron microscopy were used to study the effect of CFS against the biofilms formed by the species. The ability of CFS to interfere with yeast to hyphal transition in
Candida
was studied by colony morphology assay and visually confirmed with phase contrast microscopy. The potential of the CFS of the probiotics was also evaluated using goat buccal tissue, a novel
ex-vivo
model that mimics the vaginal environment. Moreover, the supernatant extracted from VSL-3 had the ability to down-regulate the expression of virulence genes of
Candida
from the biofilm formed over the
ex-vivo
model. These results emphasize the anti-fungal and anti-infective properties of the CFS of VSL-3 against drug-resistant
Candida
strains causing vulvovaginal candidiasis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0003-6072 1572-9699 1572-9699 |
DOI: | 10.1007/s10482-024-01929-1 |